HCR 7 (BR 433) - M. Cherry
Urge the United States Congress, Department of Health and Human Services, and Food and Drug Administration to limit, ban, or otherwise impose strict standards on direct-to-consumer advertising of drugs by pharmaceutical companies.
HCR 7 - AMENDMENTS
HCS - Retain provisions of resolution, except add that Congress study the effects of direct-to-consumer advertising on all prescriber/patient relationships, rather than just the physician/patient relationship.
(Prefiled by the sponsor(s))
Jan 8-introduced in House; to Health and Welfare (H)
Jan 14-posted in committee
Jan 17-reported favorably, 1st reading, to Calendar with Committee Substitute
Jan 18-2nd reading, to Rules; posted for passage in the Regular Orders of the Day for Tuesday, January 22, 2002
Jan 23-3rd reading, adopted 93-1 with Committee Substitute
Jan 24-received in Senate
Jan 29-to Judiciary (S)
|
